Drug susceptibility tests for Mycobacterium tuberculosis
Descripción del Articulo
Inadequate treatment regimens and poor compliance have led to increased rates of drug resistance in Mycobacterium tuberculosis around the world, leading to the emergence of multidrug resistant (MDR) and extensively drug resistant (XDR) strains. In Peru MDR-TB rates are amongst the highest in the wor...
| Autores: | , , |
|---|---|
| Formato: | artículo |
| Fecha de Publicación: | 2020 |
| Institución: | Colegio Médico del Perú |
| Repositorio: | Acta Médica Peruana |
| Lenguaje: | español |
| OAI Identifier: | oai:ojs.pkp.sfu.ca:article/1428 |
| Enlace del recurso: | https://amp.cmp.org.pe/index.php/AMP/article/view/1428 |
| Nivel de acceso: | acceso abierto |
| Materia: | Tuberculosis Drug susceptibility tests Diagnosis |
| id |
REVCMP_330004402e01d69fc9759b7bb33efd16 |
|---|---|
| oai_identifier_str |
oai:ojs.pkp.sfu.ca:article/1428 |
| network_acronym_str |
REVCMP |
| network_name_str |
Acta Médica Peruana |
| repository_id_str |
. |
| spelling |
Drug susceptibility tests for Mycobacterium tuberculosisPruebas de sensibilidad para Mycobacterium tuberculosisUgarte Gil, CésarPonce Alvarez, MarioJ. Moore, David A.TuberculosisDrug susceptibility testsDiagnosisInadequate treatment regimens and poor compliance have led to increased rates of drug resistance in Mycobacterium tuberculosis around the world, leading to the emergence of multidrug resistant (MDR) and extensively drug resistant (XDR) strains. In Peru MDR-TB rates are amongst the highest in the world and XDR-TB cases have been reported for almost a decade. Drug susceptibility tests detect cases with resistant strains, providing the best treatment option to the patient and diminishing the spread of the disease. This review is directed at the non-specialist physician, focusing upon the drug susceptibility tests approved by the National TB Program of Peru and others currently still under research.Los regímenes de tratamiento no adecuado y los problemas de adherencia del paciente han ocasionado que las tasas de resistencia de Mycobacterium tuberculosis hayan aumentado en el mundo, originando así la aparición de las cepas multidrogo resistentes (MDR) y con resistencia extensa a drogas (XDR). El Perú presenta altas tasas de TB-MDR, y ya se han reportado casos de TB-XDR. Las pruebas de sensibilidad buscan detectar los casos con cepas resistentes, permitiendo otorgar el mejor tratamiento al paciente y evitando la propagación de la enfermedad a otras personas. Esta revisión de pruebas de sensibilidad dirigida al médico no especialista, se ha enfocado en las pruebas de sensibilidad disponibles según la Norma Técnica para el control de la Tuberculosis y otras que se encuentran en investigación.Colegio Médico del Perú2020-08-09info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfhttps://amp.cmp.org.pe/index.php/AMP/article/view/1428ACTA MEDICA PERUANA; Vol 25 No 3 (2008); 171 - 175ACTA MEDICA PERUANA; Vol. 25 Núm. 3 (2008); 171 - 1751728-59171018-8800reponame:Acta Médica Peruanainstname:Colegio Médico del Perúinstacron:CMPspahttps://amp.cmp.org.pe/index.php/AMP/article/view/1428/878Copyright (c) 2020 ACTA MEDICA PERUANAinfo:eu-repo/semantics/openAccessoai:ojs.pkp.sfu.ca:article/14282023-07-06T05:50:41Z |
| dc.title.none.fl_str_mv |
Drug susceptibility tests for Mycobacterium tuberculosis Pruebas de sensibilidad para Mycobacterium tuberculosis |
| title |
Drug susceptibility tests for Mycobacterium tuberculosis |
| spellingShingle |
Drug susceptibility tests for Mycobacterium tuberculosis Ugarte Gil, César Tuberculosis Drug susceptibility tests Diagnosis |
| title_short |
Drug susceptibility tests for Mycobacterium tuberculosis |
| title_full |
Drug susceptibility tests for Mycobacterium tuberculosis |
| title_fullStr |
Drug susceptibility tests for Mycobacterium tuberculosis |
| title_full_unstemmed |
Drug susceptibility tests for Mycobacterium tuberculosis |
| title_sort |
Drug susceptibility tests for Mycobacterium tuberculosis |
| dc.creator.none.fl_str_mv |
Ugarte Gil, César Ponce Alvarez, Mario J. Moore, David A. |
| author |
Ugarte Gil, César |
| author_facet |
Ugarte Gil, César Ponce Alvarez, Mario J. Moore, David A. |
| author_role |
author |
| author2 |
Ponce Alvarez, Mario J. Moore, David A. |
| author2_role |
author author |
| dc.subject.none.fl_str_mv |
Tuberculosis Drug susceptibility tests Diagnosis |
| topic |
Tuberculosis Drug susceptibility tests Diagnosis |
| description |
Inadequate treatment regimens and poor compliance have led to increased rates of drug resistance in Mycobacterium tuberculosis around the world, leading to the emergence of multidrug resistant (MDR) and extensively drug resistant (XDR) strains. In Peru MDR-TB rates are amongst the highest in the world and XDR-TB cases have been reported for almost a decade. Drug susceptibility tests detect cases with resistant strains, providing the best treatment option to the patient and diminishing the spread of the disease. This review is directed at the non-specialist physician, focusing upon the drug susceptibility tests approved by the National TB Program of Peru and others currently still under research. |
| publishDate |
2020 |
| dc.date.none.fl_str_mv |
2020-08-09 |
| dc.type.none.fl_str_mv |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion |
| format |
article |
| status_str |
publishedVersion |
| dc.identifier.none.fl_str_mv |
https://amp.cmp.org.pe/index.php/AMP/article/view/1428 |
| url |
https://amp.cmp.org.pe/index.php/AMP/article/view/1428 |
| dc.language.none.fl_str_mv |
spa |
| language |
spa |
| dc.relation.none.fl_str_mv |
https://amp.cmp.org.pe/index.php/AMP/article/view/1428/878 |
| dc.rights.none.fl_str_mv |
Copyright (c) 2020 ACTA MEDICA PERUANA info:eu-repo/semantics/openAccess |
| rights_invalid_str_mv |
Copyright (c) 2020 ACTA MEDICA PERUANA |
| eu_rights_str_mv |
openAccess |
| dc.format.none.fl_str_mv |
application/pdf |
| dc.publisher.none.fl_str_mv |
Colegio Médico del Perú |
| publisher.none.fl_str_mv |
Colegio Médico del Perú |
| dc.source.none.fl_str_mv |
ACTA MEDICA PERUANA; Vol 25 No 3 (2008); 171 - 175 ACTA MEDICA PERUANA; Vol. 25 Núm. 3 (2008); 171 - 175 1728-5917 1018-8800 reponame:Acta Médica Peruana instname:Colegio Médico del Perú instacron:CMP |
| instname_str |
Colegio Médico del Perú |
| instacron_str |
CMP |
| institution |
CMP |
| reponame_str |
Acta Médica Peruana |
| collection |
Acta Médica Peruana |
| repository.name.fl_str_mv |
|
| repository.mail.fl_str_mv |
|
| _version_ |
1816075107201712128 |
| score |
13.95948 |
Nota importante:
La información contenida en este registro es de entera responsabilidad de la institución que gestiona el repositorio institucional donde esta contenido este documento o set de datos. El CONCYTEC no se hace responsable por los contenidos (publicaciones y/o datos) accesibles a través del Repositorio Nacional Digital de Ciencia, Tecnología e Innovación de Acceso Abierto (ALICIA).
La información contenida en este registro es de entera responsabilidad de la institución que gestiona el repositorio institucional donde esta contenido este documento o set de datos. El CONCYTEC no se hace responsable por los contenidos (publicaciones y/o datos) accesibles a través del Repositorio Nacional Digital de Ciencia, Tecnología e Innovación de Acceso Abierto (ALICIA).
